Validation Of anatomY-specific Aortic Valve Implantation Guided by Software Using EncantoR
Key facts
- Where
- Bad Nauheim, Bad Oeynhausen, Berlin, Dortmund, Dresden, Frankfurt, Hamburg, Kiel, Leipzig, and München, GermanySee the 11 sites
Where in Germany
- Kerckhoff-Klinik gGmbHBad Nauheim, GermanyContact: Nadia BouhdiNo longer taking part
- Herz-und Diabetes Zentrum NRWBad Oeynhausen, GermanyContact: Nadia BouhdiNo longer taking part
- Deutsches Herzzentrum der CharitéBerlin, GermanyContact: Nadia BouhdiNo longer taking part
- Klinikum Dortmund gGmbHDortmund, GermanyContact: Nadia BouhdiNo longer taking part
- St Johannes HospitalDortmund, GermanyContact: Nadia BouhdiNo longer taking part
- Herzzentrum Dresden GmbH UniversitätsklinikDresden, GermanyContact: Nadia BouhdiNo longer taking part
- Klinikum der Johann Wolfgang Goethe-Universität FrankfurtFrankfurt, GermanyContact: Nadia BouhdiNo longer taking part
- UKE Hamburg (Universitatsklinik Eppendorf)Hamburg, GermanyContact: Nadia BouhdiNo longer taking part
- Universitätsklinikum Schleswig-Holstein, Campus KielKiel, GermanyContact: Nadia BouhdiNo longer taking part
- Herzzentrum Leipzig GmbHLeipzig, GermanyContact: Nadia BouhdiNo longer taking part
- TUM Klinikum - Deutsches Herzzentrum MünchenMünchen, GermanyContact: Nadia BouhdiNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Abbott Medical Devices
- Trial code
- NCT07696182
- Record updated
- 12 November 2026
- Original description
VOYAGER CE Clinical Study using the Encantor TAVI System.Read full original descriptionShow less
VOYAGER CE Clinical Trial : Validation Of anatomY-specific Aortic Valve Implantation Guided by Software Using EncantoR
VOYAGER CE Clinical Study using the Encantor TAVI System.
Inclusion: Subject identified as appropriate for transcatheter heart valve intervention therapy for the treatment of symptomatic, severe aortic stenosis; Subject is of legal age for consent (18 years old); Willing to return for required follow-up visits and assessments.
Exclusion: Need for emergency surgery for any reason; Currently participating in an investigational drug or device study that has not reached the primary endpoint or may confound the results of this trial; Anatomic or comorbid conditions; Pregnant or nursing subjects.